Related Experiment Video
Updated: May 27, 2026
07:34
Generation and Labeling of Murine Bone Marrow-derived Dendritic Cells with Qdot Nanocrystals for Tracking Studies
Published on: June 2, 2011
A local role for CD103+ dendritic cells in atherosclerosis
Sammy Bedoui1, William R Heath
1Department of Microbiology & Immunology, The University of Melbourne, Parkville 3010, Victoria, Australia.
Immunity
|November 29, 2011
Summary
Conventional dendritic cells (DCs) expressing CD103 were found in mouse aortic vessels. These cells may offer protection against atherosclerosis development.
Area of Science:
- Immunology
- Cardiovascular Biology
- Cellular Biology
Background:
- Atherosclerosis is a chronic inflammatory disease affecting arteries.
- The cellular mechanisms underlying atherosclerosis are complex and not fully understood.
- Dendritic cells (DCs) play a role in immune responses and inflammation.
Discussion:
- Choi et al. investigated the cellular makeup of aortic vessels in mice with and without atherosclerosis.
- The study identified a specific subset of DCs, CD103(+) DCs, within the aortic vasculature.
- These CD103(+) DCs were present in both normal and atherosclerotic conditions.
Key Insights:
- Conventional CD103(+) DCs reside in the aortic vessels.
- The presence of CD103(+) DCs suggests a potential role in modulating the atherosclerotic process.
- This finding points to a possible protective function of these immune cells in atherosclerosis.
Outlook:
- Further research is needed to elucidate the precise mechanisms by which CD103(+) DCs influence atherosclerosis.
- Targeting CD103(+) DCs could represent a novel therapeutic strategy for preventing or treating atherosclerosis.
- Understanding the immune cell composition of blood vessels is crucial for developing cardiovascular disease therapies.
Related Concept Videos
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:38Inflammation
Overview
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:30Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...